MediPharm Labs Corp. (TSE:LABS – Get Free Report) shares reached a new 52-week low on Wednesday . The stock traded as low as C$0.06 and last traded at C$0.07, with a volume of 659415 shares traded. The stock had previously closed at C$0.07.
MediPharm Labs Price Performance
The stock has a market cap of C$26.72 million, a P/E ratio of -1.63 and a beta of 0.88. The company has a quick ratio of 3.10, a current ratio of 3.11 and a debt-to-equity ratio of 5.90. The business has a 50-day simple moving average of C$0.07 and a 200-day simple moving average of C$0.07.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Read More
- Five stocks we like better than MediPharm Labs
- What to Know About Investing in Penny Stocks
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Why is the Ex-Dividend Date Significant to Investors?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
